Skip to content

Gaviscon Adapted Formulation Mint 250 mg (alginaat natrium 250 mg + waterstofcarbonaat natrium 133,5 mg + carbonaat calcium 80 mg kauwtablet (or.)) · CNK 2308245

Product information

Gaviscon Adapted Formulation Mint 250 mg
48
alginaat natrium 250 mg + waterstofcarbonaat natrium 133,5 mg + carbonaat calcium 80 mg kauwtablet (or.)
2308245
9.86 / 10
Locked

Product properties

9005-38-3
A02BX13
Reckitt Benckiser (Healthcare)
Chewable tablet
BE271801
FD
Public
271801-07

Pharmacist Assessment

Officially temporarily unavailable, remaining stock at wholesaler

This product is officially reported as temporarily unavailable (reason: Delay in production), but remaining stock is available at wholesalers (score 9.86/10). This stock may run out quickly. Order in time or switch to an alternative.

No medicinal alternative available. Consider magistral preparation — active substance available from Fagron.

Equivalent products

Tier A: Direct equivalents

…

Tier B: Galenic alternatives

…

Tier C: Strength alternatives

…

Tier D: ATC equivalents (parallel import)

…

Tier E: Active substances (magistral)

…

Stock overview

Availability in Freemium
  • 17 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Temporarily unavailable Active
-

Delay in production

Adaptation of the treatment possible (non-vital medicinal product)

Composition

6 ingredients

Substance Type Strength CAS
Active ingredient
250 mg
9005-38-3
Active ingredient
80 mg
471-34-1
Active ingredient
133.5 mg
144-55-8
Excipient
255 mg
Excipient
3.75 mg
Excipient
3.75 mg

Additional information

Availability statistics

Temporarily unavailable
2 days
3
1
28/10/2026